RhoG
RhoG is a small GTPase belonging to the Rho family of proteins, which play a critical role in regulating the cytoskeleton, cell migration, cell proliferation, and cell survival. RhoG is involved in various cellular processes, including changes in cell morphology, gene expression, and the activation of enzymes that modify other proteins. It is encoded by the RHOG gene in humans.
Function[edit | edit source]
RhoG is a molecular switch that cycles between an active GTP-bound state and an inactive GDP-bound state. It is activated by guanine nucleotide exchange factors (GEFs) that facilitate the exchange of GDP for GTP. Once activated, RhoG interacts with a variety of downstream effectors to initiate changes in the actin cytoskeleton, leading to cell shape alterations, movement, and adhesion. RhoG has been implicated in the regulation of endocytosis, cell adhesion, neurite outgrowth, and cell migration, making it a critical player in developmental processes, wound healing, and cancer metastasis.
Signaling Pathways[edit | edit source]
RhoG operates within complex signaling networks and can be activated by various extracellular signals, including growth factors, cytokines, and extracellular matrix components. Upon activation, RhoG can influence several downstream pathways, notably those involving the Rac1 and Cdc42 GTPases, which further modulate the actin cytoskeleton. Through its effectors, RhoG is also involved in the regulation of NADPH oxidase activity, contributing to the production of reactive oxygen species (ROS) and the modulation of cellular redox states.
Clinical Significance[edit | edit source]
Alterations in RhoG expression or activity have been associated with various pathologies, including cancer, neurodegenerative diseases, and inflammatory diseases. In cancer, RhoG has been shown to play roles in tumor cell invasion and metastasis. Its involvement in the regulation of cell migration and adhesion makes it a potential target for therapeutic intervention in cancer and other diseases characterized by abnormal cell movement and invasion.
Research[edit | edit source]
Ongoing research is focused on elucidating the detailed mechanisms by which RhoG regulates the cytoskeleton and cell movement, as well as its interactions with other signaling molecules. Understanding the precise role of RhoG in disease progression and its potential as a therapeutic target remains a significant area of interest.
See Also[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD